Atezolizumab,vinorelbine
roche
['tecentriq', 'lung', 'nsclc', 'atezo', 'sclc']
the immune checkpoint inhibitor atezolizumab (tecentriq) improved overall survival compared with chemotherapy in patients with advanced #nsclc who were ineligible for platinum doublet chemotherapy. #esmo22 #lungcancer 
OBR is an oncology-focused digital media company that provides news and information resources to oncology professionals.